missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CD263 (TRAIL-R3) Monoclonal Antibody (TRAIL-R3-02), PE, Invitrogen™
Mouse Monoclonal Antibody
Marque: Invitrogen MA110162
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
TRAIL-R3 (CD263) is a member of the TNF-receptor superfamily. This receptor contains an extracellular TRAIL-binding domain and a transmembrane domain, but no cytoplasmic death domain. This receptor is not capable of inducing apoptosis, and is thought to function as an antagonistic receptor that protects cells from TRAIL-induced apoptosis. This gene was found to be a p53-regulated DNA damage-inducible gene. The expression of this gene was detected in many normal tissues but not in most cancer cell lines, which may explain the specific sensitivity of cancer cells to the apoptosis-inducing activity of TRAIL.
Spécification
| CD263 (TRAIL-R3) | |
| Monoclonal | |
| 0.1 mg/mL | |
| PBS with 0.2% BSA and 15mM sodium azide; pH 7.4 | |
| O14798 | |
| TNFRSF10C | |
| TRAIL-R3-hIgGhc fusion protein | |
| 100 μg | |
| Primary | |
| Human | |
| Antibody | |
| IgG1 |
| Flow Cytometry | |
| TRAIL-R3-02 | |
| PE | |
| TNFRSF10C | |
| Antagonist decoy receptor for TRAIL/Apo-2L; CD263; cytotoxic TRAIL receptor-3; DCR1; DCR1-TNFR; Decoy receptor 1; decoy TRAIL receptor without death domain; LIT; lymphocyte inhibitor of TRAIL; MGC149501; MGC149502; TNF receptor superfamily member 10c; TNF-related apoptosis-inducing ligand receptor 3; TNFRSF10C; TRAIL receptor 3; TRAIL receptor without an intracellular domain; TRAILR3; TRAIL-R3; TRID; Tumor necrosis factor receptor superfamily member 10C; tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain; UNQ321/PRO366 | |
| Mouse | |
| Size-exclusion chromatography | |
| RUO | |
| 8794 | |
| 4° C, store in dark, DO NOT FREEZE! | |
| Liquid |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
CD263 (TRAIL-R3) Monoclonal Antibody (TRAIL-R3-02), PE, Invitrogen™ > 100 μg; PE
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu
